Former Italy striker Rossi avoids doping ban

2018-10-01 18:03
Giuseppe Rossi
Giuseppe Rossi (Getty Images)

Milan - Former Genoa and Italy striker Giuseppe Rossi on Monday avoided a doping ban after testing positive for the banned substance dorzolamide.

Italy's anti-doping prosecutor was seeking a one-year ban but the 31-year-old was given only a reprimand following Monday's hearing.

The amount of dorzolamide found during the drug test was minimal, Rossi's lawyer Sergio Puglisi Maraja said after the hearing.

"We don't understand how this substance ended up among Rossi's foods, there was no intentionality, the line of good faith and consistency prevailed," his lawyer added.

Dorzolamide is commonly found in eye drops. Its use is permitted if the athlete obtains a therapeutic use exemption, although if not applied to the eyes, it could be used as a diuretic or masking agent.

Rossi, who has played 30 times for the Azzurri in a career blighted by knee injuries, tested positive following an Italian league match between his team at the time, Genoa, and Benevento on May 12.

Rossi formerly played for Manchester United and Fiorentina but is without a club.

The US-born player, who maintained his innocence, left Genoa over the summer. He is now free to continue his playing career.

Read more on:    soccer


Read News24’s Comments Policy

Love 2 Meet
Sport24 on Twitter

Follow Sport24 news on Twitter


The 2019/20 Absa Premiership season is in full swing. Will Mamelodi Sundowns retain their title? Or can one of Kaizer Chiefs, Orlando Pirates, Wits, SuperSport United - or another team perhaps - snatch glory from the Brazilians? Be sure to visit Sport24 for all the latest news!

Latest blogs

After Stuart Baxter stepped down as Bafana Bafana head coach, who would you like to see take over?

Twitter Follow Sport24 on Twitter

Facebook "Like" Sport24's Facebook page

WIN Enter and win with Sport24!

BlackBerry Stay in the loop on your BlackBerry

RSS Feeds Sport news delivered really simply.

There are new stories on the homepage. Click here to see them.